Ledger.Open graph →
SEC Form D · filed October 5, 2017

Juno Therapeutics, Inc

Offering
$31.1M
Sold
$31.1M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (28)

Mary A. Wilderotter · Seattle, WADirectorHal J. Barron · Seattle, WADirectorRichard J. Klausner · Seattle, WADirector · PromoterAnthony J. Evnin · Seattle, WADirectorRobert J. Nelsen · Seattle, WADirector · PromoterSteven Harr · Seattle, WAExecThomas A. Daniel · Seattle, WADirectorHoward J. Pien · Seattle, WADirectorHans Bishop · Seattle, WAExec · Director · PromoterBernard J. Cassidy · Seattle, WAExecJay J. Flatley · Seattle, WADirectorSunil Agarwal · Seattle, WAExecRobert Azelby · Seattle, WAExecRupert A. Vessey · Seattle, WADirectorMary A. Wilderotter · Seattle, WADirectorHal J. Barron · Seattle, WADirectorRichard J. Klausner · Seattle, WADirector · PromoterAnthony J. Evnin · Seattle, WADirectorRobert J. Nelsen · Seattle, WADirector · PromoterSunil Agarwal · Seattle, WAExecSteven Harr · Seattle, WAExecRobert Azelby · Seattle, WAExecThomas A. Daniel · Seattle, WADirectorHoward J. Pien · Seattle, WADirectorHans Bishop · Seattle, WAExec · Director · PromoterBernard J. Cassidy · Seattle, WAExecRupert A. Vessey · Seattle, WADirectorJay J. Flatley · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗